Drug of choice for hepatitis B:
High-Yield Explanation
Tenofovir is a first-line agent in the treatment of hepatitis B. It prevents the formation of 5' to 3' phosphodiester linkage essential for DNA chain elongation. Hence it causes premature termination of DNA transcription.